432 related articles for article (PubMed ID: 31075939)
21. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
[TBL] [Abstract][Full Text] [Related]
22. Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer.
Bednarczyk RB; Tuli NY; Hanly EK; Rahoma GB; Maniyar R; Mittelman A; Geliebter J; Tiwari RK
Oncotarget; 2018 May; 9(36):24272-24282. PubMed ID: 29849939
[TBL] [Abstract][Full Text] [Related]
23. Cross-Talk Between Tumor Cells Undergoing Epithelial to Mesenchymal Transition and Natural Killer Cells in Tumor Microenvironment in Colorectal Cancer.
Vuletić A; Mirjačić Martinović K; Tišma Miletić N; Zoidakis J; Castellvi-Bel S; Čavić M
Front Cell Dev Biol; 2021; 9():750022. PubMed ID: 34858978
[TBL] [Abstract][Full Text] [Related]
24. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
[TBL] [Abstract][Full Text] [Related]
25. EMT in Breast Carcinoma-A Review.
Felipe Lima J; Nofech-Mozes S; Bayani J; Bartlett JM
J Clin Med; 2016 Jul; 5(7):. PubMed ID: 27429011
[TBL] [Abstract][Full Text] [Related]
26. In situ localization of tumor cells associated with the epithelial-mesenchymal transition marker Snail and the prognostic impact of lymphocytes in the tumor microenvironment in invasive ductal breast cancer.
Alkatout I; Hübner F; Wenners A; Hedderich J; Wiedermann M; Sánchez C; Röcken C; Mathiak M; Maass N; Klapper W
Exp Mol Pathol; 2017 Apr; 102(2):268-275. PubMed ID: 28232080
[TBL] [Abstract][Full Text] [Related]
27. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
Li H; Xu F; Li S; Zhong A; Meng X; Lai M
Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers for EMT and MET in breast cancer: An update.
Liu F; Gu LN; Shan BE; Geng CZ; Sang MX
Oncol Lett; 2016 Dec; 12(6):4869-4876. PubMed ID: 28105194
[TBL] [Abstract][Full Text] [Related]
29. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.
Chockley PJ; Keshamouni VG
J Immunol; 2016 Aug; 197(3):691-8. PubMed ID: 27431984
[TBL] [Abstract][Full Text] [Related]
30. The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition.
Gómez-Valenzuela F; Escobar E; Pérez-Tomás R; Montecinos VP
Front Oncol; 2021; 11():686792. PubMed ID: 34178680
[TBL] [Abstract][Full Text] [Related]
31. Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response.
Lorenzo-Sanz L; Muñoz P
Cancer Microenviron; 2019 Dec; 12(2-3):119-132. PubMed ID: 31583529
[TBL] [Abstract][Full Text] [Related]
32. Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review.
Wang S; Huang S; Sun YL
Biomed Res Int; 2017; 2017():2646148. PubMed ID: 29379795
[TBL] [Abstract][Full Text] [Related]
33. Whom to blame for metastasis, the epithelial-mesenchymal transition or the tumor microenvironment?
Pietilä M; Ivaska J; Mani SA
Cancer Lett; 2016 Sep; 380(1):359-68. PubMed ID: 26791236
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer cells: Focus on the consequences of epithelial-to-mesenchymal transition.
Bong AHL; Monteith GR
Int J Biochem Cell Biol; 2017 Jun; 87():23-26. PubMed ID: 28336365
[TBL] [Abstract][Full Text] [Related]
35. Twist induces epithelial-mesenchymal transition and cell motility in breast cancer via ITGB1-FAK/ILK signaling axis and its associated downstream network.
Yang J; Hou Y; Zhou M; Wen S; Zhou J; Xu L; Tang X; Du YE; Hu P; Liu M
Int J Biochem Cell Biol; 2016 Feb; 71():62-71. PubMed ID: 26693891
[TBL] [Abstract][Full Text] [Related]
36. Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer.
Alkatout I; Wiedermann M; Bauer M; Wenners A; Jonat W; Klapper W
Exp Mol Pathol; 2013 Feb; 94(1):168-73. PubMed ID: 22985790
[TBL] [Abstract][Full Text] [Related]
37. TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance.
Ren H; Du P; Ge Z; Jin Y; Ding D; Liu X; Zou Q
J Cancer; 2016; 7(9):1074-80. PubMed ID: 27326250
[TBL] [Abstract][Full Text] [Related]
38. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
Liao TT; Yang MH
Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
[TBL] [Abstract][Full Text] [Related]
39. P-Cadherin Linking Breast Cancer Stem Cells and Invasion: A Promising Marker to Identify an "Intermediate/Metastable" EMT State.
Ribeiro AS; Paredes J
Front Oncol; 2014; 4():371. PubMed ID: 25601904
[TBL] [Abstract][Full Text] [Related]
40. Adipose MSCs Suppress MCF7 and MDA-MB-231 Breast Cancer Metastasis and EMT Pathways Leading to Dormancy via Exosomal-miRNAs Following Co-Culture Interaction.
Mohd Ali N; Yeap SK; Ho WY; Boo L; Ky H; Satharasinghe DA; Tan SW; Cheong SK; Huang HD; Lan KC; Chiew MY; Ong HK
Pharmaceuticals (Basel); 2020 Dec; 14(1):. PubMed ID: 33374139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
